COYA Historical PE Ratio Notes

— Coya Therapeutics (ticker: COYA) is a clinical-stage biotechnology company focused on developing innovative therapies targeting neurodegenerative and autoimmune diseases, including ALS (Amyotrophic Lateral Sclerosis), Alzheimer’s, and Parkinson’s Disease. The company's pipeline leverages advancements in regulatory T-cell (Treg) biology and immunomodulation, aiming to address unmet medical needs through precise, disease-modifying treatments. When researching COYA’s historical PE (price-to-earnings) ratio, it's important to recognize that as a pre-revenue or early-revenue biotech firm, COYA may exhibit highly volatile or even negative earnings, especially during periods when significant investments in R&D and clinical trials typically outpace potential revenues. Consequently, past PE ratios may have been undeterminable (N/A or negative) or extremely high, reflecting the inherent risk, speculative nature, and future-growth orientation that the market often assigns to biotech startups. As you review historical price & earnings data, be mindful that changes in COYA’s operational phase, milestone achievements, clinical trial results, and evolving expectations for future commercialization have critical impacts on both earnings and the corresponding PE ratio, making these metrics different in meaning and use compared to mature, profit-generating companies.

On this page we presented the COYA Historical PE Ratio information for Coya Therapeutics' stock. The average COYA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 16.8. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average COYA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this COYA historical PE result, against the recent PE: when this page was posted on 9/4/2026, the most recent closing price for COYA had been 4.76, and the most recent quarterly earnings result, annualized, was 0.6. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent COYA PE on 9/4/2026 based on annualized quarterly EPS was 7.9. Based on COYA's history, that recent PE is low relative to the historical average, with the recent PE 53.0% lower than the historical average PE across our data set for Coya Therapeutics.

For self directed investors doing their due diligence on COYA or any other given stock, valuation analysis for COYA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Coya Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for COYA. Thanks for visiting, and the next time you need to research COYA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.